UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol

Arthritis research & therapy, 2021-10, Vol.23 (1), p.1-274, Article 274

2021

Volltextzugriff (PDF)

Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status

Rheumatic & musculoskeletal diseases open, 2024-05, Vol.10 (2), p.e003884

2024

Volltextzugriff (PDF)

Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol

Therapeutic advances in musculoskeletal disease, 2022-04, Vol.14, p.1759720X221087650-1759720X221087650

2022

Volltextzugriff (PDF)

Certolizumab Pegol Efficacy in Patients With Non‐Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C‐Reactive Protein Status: An Analysis From the C‐axSpAnd Study

ACR open rheumatology, 2022-09, Vol.4 (9), p.794-801

2022

Volltextzugriff (PDF)

Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study

Rheumatic & musculoskeletal diseases open, 2022-03, Vol.8 (1), p.e002138

2022

Volltextzugriff (PDF)

Macroinvertebrate community structure in agricultural streams: impact of runoff-related pesticide contamination

Ecotoxicology and environmental safety, 2005, Vol.60 (1), p.37-46

2005

Volltextzugriff (PDF)

OA11 Maintained improvement in patient reported outcomes in early axial spondyloarthritis following certolizumab pegol dose reduction

Rheumatology (Oxford, England), 2024-04, Vol.63 (Supplement_1)

2024

Volltextzugriff (PDF)

Lacosamide and pregnancy: Data from spontaneous and solicited reports

Epilepsia (Copenhagen), 2024-05, Vol.65 (5), p.1275-1284

2024

Volltextzugriff (PDF)

Certolizumab pegol treatment in axial spondyloarthritis mitigates fat lesion development: 4-year post-hoc MRI results from a phase 3 study

Rheumatology (Oxford, England), 2022-07, Vol.61 (7), p.2875-2885

2022

Volltextzugriff (PDF)

Limnological characteristics of lakes in the lowlands of Central Yakutia, Russia

Journal of limnology, 2007-02, Vol.66 (1), p.40-53

2007

Volltextzugriff (PDF)

Chironomid-based inference models for estimating mean July air temperature and water depth from lakes in Yakutia, northeastern Russia

Journal of paleolimnology, 2011-01, Vol.45 (1), p.57-71

2011

Volltextzugriff (PDF)

S753 Pharmacovigilance Data on Pregnancy Outcomes in Women With Crohn’s Disease Exposed to Certolizumab Pegol

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S347-S347

2021

Volltextzugriff (PDF)

188 Real-world data on the use of certolizumab pegol for the treatment of axial spondyloarthritis in clinical practice in Europe: 24-week interim results from a prospective non-interventional cohort study

Rheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3)

2018

Volltextzugriff (PDF)

P284 Certolizumab pegol-treated patients with non-radiographic axSpA demonstrate improvements in sleep quality and other patient reported outcomes

Rheumatology (Oxford, England), 2020-04, Vol.59 (Supplement_2)

2020

Volltextzugriff (PDF)

Lack of effect of lacosamide on the pharmacokinetic and pharmacodynamic profiles of warfarin

Epilepsia (Copenhagen), 2013-07, Vol.54 (7), p.1161-1166

2013

Volltextzugriff (PDF)

Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland

Advances in therapy, 2018-09, Vol.35 (9), p.1426-1437

2018

Volltextzugriff (PDF)

Validation of the GetReal Trial Tool – Facilitating discussion and understanding more pragmatic design choices and their implications

Contemporary clinical trials, 2023-02, Vol.125, p.107054-107054, Article 107054

2023

Volltextzugriff (PDF)

Improvements in productivity and increased participation in daily activities over 52 weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observational study

Acta clinica belgica (English ed. Online), 2019-10, Vol.74 (5), p.342-350

2019

Volltextzugriff (PDF)

P242 CZP improves work and household productivity and social participation over 1 year of treatment in patients with non-radiographic axSpA

Rheumatology (Oxford, England), 2020-04, Vol.59 (Supplement_2)

2020

Volltextzugriff (PDF)

090Achievement of Treatment Response with Certolizumab Pegol: Results from an Interim Analysis of Proactive, A Non-Interventional Study in Real-Life Rheumatoid Arthritis Patients in the UK and Ireland

Rheumatology (Oxford, England), 2016-04, Vol.55 (suppl_1), p.i99-i99

2016

Volltextzugriff (PDF)

Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study

Advances in therapy, 2018-08, Vol.35 (8), p.1153-1168

2018

Volltextzugriff (PDF)

Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review

Rheumatology and therapy., 2022-12, Vol.9 (6), p.1481-1497

2022

Volltextzugriff (PDF)

Deposit and Geoenvironmental Models for Resource Exploitation and Environmental Security

Mathematical geology, 2005-04, Vol.37 (3), p.321-322

Kumke, Thomas

2005

Volltextzugriff (PDF)

Pharmacokinetic properties of isosorbide-5-mononitrate under fasting and fed conditions in healthy male subjects

International journal of clinical pharmacology and therapeutics, 2015-01, Vol.53 (1), p.97

2015

Volltextzugriff (PDF)

Combining ordination techniques and geostatistics to determine the patterns of diatom distributions at Lake Lama, Central Siberia

Journal of paleolimnology, 2002-08, Vol.28 (2), p.181-194

2002

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Englisch
(53)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol

Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status

Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol

Certolizumab Pegol Efficacy in Patients With Non‐Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C‐Reactive Protein Status: An Analysis From the C‐axSpAnd Study

Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study

Macroinvertebrate community structure in agricultural streams: impact of runoff-related pesticide contamination

OA11 Maintained improvement in patient reported outcomes in early axial spondyloarthritis following certolizumab pegol dose reduction

Lacosamide and pregnancy: Data from spontaneous and solicited reports

Certolizumab pegol treatment in axial spondyloarthritis mitigates fat lesion development: 4-year post-hoc MRI results from a phase 3 study

Limnological characteristics of lakes in the lowlands of Central Yakutia, Russia

Chironomid-based inference models for estimating mean July air temperature and water depth from lakes in Yakutia, northeastern Russia

S753 Pharmacovigilance Data on Pregnancy Outcomes in Women With Crohn’s Disease Exposed to Certolizumab Pegol

188 Real-world data on the use of certolizumab pegol for the treatment of axial spondyloarthritis in clinical practice in Europe: 24-week interim results from a prospective non-interventional cohort study

P284 Certolizumab pegol-treated patients with non-radiographic axSpA demonstrate improvements in sleep quality and other patient reported outcomes

Lack of effect of lacosamide on the pharmacokinetic and pharmacodynamic profiles of warfarin

Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland

Validation of the GetReal Trial Tool – Facilitating discussion and understanding more pragmatic design choices and their implications

Improvements in productivity and increased participation in daily activities over 52 weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observational study

P242 CZP improves work and household productivity and social participation over 1 year of treatment in patients with non-radiographic axSpA

090Achievement of Treatment Response with Certolizumab Pegol: Results from an Interim Analysis of Proactive, A Non-Interventional Study in Real-Life Rheumatoid Arthritis Patients in the UK and Ireland

Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results from the CZP-SPEED Study

Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review

Deposit and Geoenvironmental Models for Resource Exploitation and Environmental Security

Pharmacokinetic properties of isosorbide-5-mononitrate under fasting and fed conditions in healthy male subjects

Combining ordination techniques and geostatistics to determine the patterns of diatom distributions at Lake Lama, Central Siberia

Suchergebnisse filtern